U.S. Joins Pfizer Suit Over Drug’s Marketing
The drug maker and its Wyeth unit are accused by two whistle-blowers of illegal off-label marketing of a drug used to prevent rejection of kidney transplants. (Source: NYT)

Recalls and Safety Alerts: Increased Mortality in Liver Transplant Patients Treated with Rapamune
FDA is alerting healthcare professionals that stable liver transplant patients may have an increased risk of death if they are switched from an immunosuppressive regimen based on a calcineurin inhibitor (CNI) to sirolimus. Sirolimus, which is market... (Source: Food and Drug Adminstration (FDA): Patient Safety News)div id=medwormpbiMedWorm Message:/i/b Please support the a href=http://www.doctorsinchains.org/ target=_blankDoctors In Chains/a campaign for the a href=http://www.doctorsinchains.org/medics/a tortured and sentenced for up to 15 years in a href=http://www.doctorsinchains.org/Bahrain/a. a href=https://twitter.com/#!/search/%23FreeDoctors#FreeDoctors/a/p/div